Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007167 |
---|---|
Receipt number | R000008446 |
Scientific Title | Phase I/II clinical trial of immunoRFA with OK-432 for patients with lung cancer |
Date of disclosure of the study information | 2012/02/01 |
Last modified on | 2019/09/01 01:12:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/01/30 18:49:41 | ||
2 | Update | 2012/07/30 12:53:15 | Recruitment status |
|
3 | Update | 2016/03/09 12:55:43 | Email Institute Institute Organization Organization |
|
4 | Update | 2016/03/09 12:56:27 | Key inclusion criteria |
|
5 | Update | 2016/08/03 11:32:48 | Name of primary person or sponsor Organization |
|
6 | Update | 2016/08/03 11:44:05 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
7 | Update | 2019/08/26 00:21:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
8 | Update | 2019/09/01 01:11:39 | Date of IRB Last follow-up date Other related information Other related information |
|
9 | Update | 2019/09/01 01:12:43 | Recruitment status |